OmniSonics Medical Technologies

OmniSonics Medical Technologies is a U.S.-based company specializing in developing medical devices for treating vascular occlusive diseases. Their slogan "Harness the power of ultrasonic innovation to clear vascular pathways and restore healthy blood flow rapidly and safely" underscores their use of transverse, ultrasonic energy to clear obstructions caused by thrombus in arteries or veins. Employing low power ultrasonic energy, the company creates cavitational streaming that dissolves thrombus swiftly and restores blood flow efficiently without damaging surrounding vessel walls. Their flagship product, the OmniWave Endovascular System, designed to infuse physician-specified fluids and remove thrombus in the peripheral vasculature, reflects their commitment to innovation in healthcare. Established in 1998, with a focus on Health Care and Life Sciences industries, the company secured a significant Series D investment of $20.00M on 19 July 2007. Although specific investors for this round were not disclosed, this investment likely played a crucial role in the development and commercialization of their groundbreaking technologies. With its headquarters in Lakewood, New York, OmniSonics Medical Technologies continues to be an exciting player in the medical technology space.